FDA fast tracks epcoritamab for follicular lymphoma

COPENHAGEN - The U.S. Food and Drug Administration (FDA) has granted Priority Review for epcoritamab, a potential new treatment for patients with relapsed or refractory follicular lymphoma, announced Genmab A/S (NASDAQ: NASDAQ:GMAB) and AbbVie (NYSE: NYSE:ABBV). This designation could significantly expedite the therapy\'s approval process, with a target action date set for June 28, 2024....

Read More

Bay Street May Open On Weak Note

The Canadian market is likely to open on a weak note Tuesday morning as lower crude oil prices may weigh on energy stocks. Movements are likely to be a bit volatile with investors looking for directional clues. Geopolitical news will remain in focus, and investors are also likely to closely monitor the movement of Hurricane...

Read More

NeuroBo Pharmaceuticals Confirms Marshall Woodworth As New CFO

Biotechnology company NeuroBo Pharmaceuticals, Inc. (NRBO) announced Monday the appointment of Marshall Woodworth as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, effective March 1, 2024, following his tenure as Acting Chief Financial Officer since October 27, 2023. Marshall brings in decades of experience as a CFO for a variety of pharmaceutical and...

Read More